Lung function in children and adolescents with juvenile idiopathic arthritis during long-term treatment with methotrexate: A retrospective study

Clinical and Experimental Rheumatology

Volumn 30, Issue 2, 2012, Pages 302-307

  Leiskau, Christoph ^a,b   Thon, Angelika ^a   Gappa, Monika ^a,c   Dressler, Frank ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Klinikum Hildesheim   (Germany)

^c Marien Hospital   (Germany)

Author keywords

Juvenile idiopathic arthritis; Methotrexate; Pulmonary function

Indexed keywords

CARBON MONOXIDE; METHOTREXATE;

ADOLESCENT; ARTICLE; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG SAFETY; EXPIRATORY FLOW; FEMALE; FORCED EXPIRATORY VOLUME; FUNCTIONAL RESIDUAL CAPACITY; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; LONG TERM CARE; LUNG CAPACITY; LUNG DIFFUSION CAPACITY; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MAXIMAL EXPIRATORY FLOW; PLETHYSMOGRAPHY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SINGLE DRUG DOSE; SPIROMETRY; TREATMENT DURATION; VITAL CAPACITY;

ADOLESCENT; AGE OF ONSET; ARTHRITIS, JUVENILE RHEUMATOID; CHILD; CHILD, PRESCHOOL; FEMALE; FORCED EXPIRATORY VOLUME; GERMANY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LINEAR MODELS; LUNG; MALE; METHOTREXATE; PULMONARY DIFFUSING CAPACITY; PULMONARY VENTILATION; RESPIRATORY FUNCTION TESTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84863766740     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. GIANNINI EH, BREWER EJ, KUZMINA N et al.: Methotrexate in resistant juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled trial. The Pediatric Rheumatology Collaborative Study Group and The Cooperative Children's Study Group. N Engl J Med 1992; 326: 1043-9.
2. GUTIERREZ-SUAREZ R, BURGOS-VARGAS R: The use of methotrexate in children with rheumatic diseases. Clin Exp Rheumatol 2010; 28 (Suppl. 61):S122-7.
3. YAZICI Y: Long-term safety of methotrexate in the treatment of rheumatoid arthritis. Clin Exp Rheumatol 2010; 28 (Suppl. 61): S65-7.
4. ALBRECHT K, MULLER-LADNER U: Side effects and management of side effects of methotrexate in rheumatoid arthritis. Clin Exp Rheumatol 2010; 28 (Suppl. 61): S95-101.
5. LAHDENNE P, RAPOLA J, YLIJOKI H, HAAPASAARI J: Hepatotoxicity in patients with juvenile idiopathic arthritis receiving longterm methotrexate therapy. J Rheumatol 2002 Nov; 29: 2442-5.
6. SCHNABEL A, GROSS WL: Low-dose methotrexate in rheumatic diseases-efficacy, side effects, and risk factors for side effects. Semin Arthritis Rheum 1994 Apr; 23: 310-27.
7. HILLIQUIN P, RENOUX M, PERROT S, PUECHAL X, MENKES CJ: Occurrence of pulmonary complications during methotrexate therapy in rheumatoid arthritis. Br J Rheumatol 1996; 35: 441-5.
8. KREMER JM, ALARCON GS, WEINBLATT ME et al.: Clinical, laboratory, radiographic, and histopathologic features of methotrexate-associated lung injury in patients with rheumatoid arthritis: a multicenter study with literature review. Arthritis Rheum 1997; 40: 1829-37.
9. VAN DER VEEN MJ, DEKKER JJ, DINANT HJ, VAN SOESBERGEN RM, BIJLSMA JW: Fatal pulmonary fibrosis complicating low dose methotrexate therapy for rheumatoid arthritis. J Rheumatol 1995; 22: 1766-8.
10. KHADADAH ME, JAYAKRISHNAN B, ALGORAIR S et al.: Effect of methotrexate on pulmonary function in patients with rheumatoid arthritis-a prospective study. Rheumatol Int 2002; 22: 204-7.
11. COTTIN V, TEBIB J, MASSONNET B, SOUQUET PJ, BERNARD JP: Pulmonary function in patients receiving long-term low-dose methotrexate. Chest 1996; 109: 933-8.
12. CAMICIOTTOLI G, TRAPANI S, CASTELLANI W, GINANNI R, ERMINI M, FALCINI F: Effect on lung function of methotrexate and nonsteroid anti-inflammatory drugs in children with juvenile rheumatoid arthritis. Rheumatol Int 1998; 18: 11-6.
13. SCHMELING H, STEPHAN V, BURDACH S, HORNEFF G: Pulmonary function in children with juvenile idiopathic arthritis and effects of methotrexate therapy. Z Rheumatol 2002; 61: 168-72.
14. PELUCCHI A, LOMATER C, GERLONI V, FORESI A, FANTINI F, MARAZZINI L: Lung function and diffusing capacity for carbon monoxide in patients with juvenile chronic arthritis: effect of disease activity and low dose methotrexate therapy. Clin Exp Rheumatol 1994; 12: 675-9.
15. MILLER MR, HANKINSON J, BRUSASCO V et al.: Standardisation of spirometry. Eur Respir J 2005; 26: 319-38.
16. QUANJER PH, STOCKS J, POLGAR G, WISE M, KARLBERG J, BORSBOOM G: Compilation of reference values for lung function measurements in children. Eur Respir J Suppl 1989; 4: 184S-261S.
17. COTTIN V, TEBIB J, MASSONNET B, SOUQUET PJ, BERNARD JP: [Respiratory function surveillance during prolonged treatment with low-dose methotrexate]. Presse Med 1997; 26: 404-6.
18. AYHAN-ARDIC FF, OKEN O, YORGANCIOGLU ZR, USTUN N, GOKHARMAN FD: Pulmonary involvement in lifelong non-smoking patients with rheumatoid arthritis and ankylosing spondylitis without respiratory symptoms. Clin Rheumatol 2006; 25: 213-8.
19. BILGICI A, ULUSOY H, KURU O, CELENK C, UNSAL M, DANACI M: Pulmonary involvement in rheumatoid arthritis. Rheumatol Int 2005; 25: 429-35.
20. GOCHUICO BR, AVILA NA, CHOW CK et al.: Progressive preclinical interstitial lung disease in rheumatoid arthritis. Arch Intern Med 2008; 168: 159-66.
21. DAWSON JK, GRAHAM DR, DESMOND J, FEWINS HE, LYNCH MP: Investigation of the chronic pulmonary effects of low-dose oral methotrexate in patients with rheumatoid arthritis: a prospective study incorporating HRCT scanning and pulmonary function tests. Rheumatology (Oxford) 2002; 41: 262-7.
22. OKUDA Y, TAKASUGI K, IMAI A, OYAMA T, OYAMA H, KAWAMURA S: [Clinical study of rheumatoid interstitial lung disease evaluated by high resolution CT]. Ryumachi 1993; 33: 12-9.
23. CANNON GW: Methotrexate pulmonary toxicity. Rheum Dis Clin North Am 1997; 23: 917-37.
24. DAYTON CS, SCHWARTZ DA, SPRINCE NL et al.: Low-dose methotrexate may cause air trapping in patients with rheumatoid arthritis. Am J Respir Crit Care Med 1995; 151: 1189-93.
25. ARAKAWA H, YAMASAKI M, KURIHARA Y, YAMADA H, NAKAJIMA Y: Methotrexate-induced pulmonary injury: serial CT findings. J Thorac Imaging 2003; 18: 231-6.
26. CRON RQ, SHERRY DD, WALLACE CA: Methotrexate-induced hypersensitivity pneumonitis in a child with juvenile rheumatoid arthritis. J Pediatr 1998; 132: 901-2.
27. GRAHAM LD, MYONES BL, RIVAS-CHACON RF, PACHMAN LM: Morbidity associated with long-term methotrexate therapy in juvenile rheumatoid arthritis. J Pediatr 1992; 120: 468-73.
28. WALLACE CA, BLEYER WA, SHERRY DD, SALMONSON KL, WEDGWOOD RJ: Toxicity and serum levels of methotrexate in children with juvenile rheumatoid arthritis. Arthritis Rheum 1989; 32: 677-81.
29. WAGENER JS, TAUSSIG LM, DEBENEDETTI C, LEMEN RJ, LOUGHLIN GM: Pulmonary function in juvenile rheumatoid arthritis. J Pediatr 1981; 99: 108-10.
30. KNOOK LM, DE KLEER IM, VAN DER ENT CK, VAN DER NET JJ, PRAKKEN BJ, KUIS W: Lung function abnormalities and respiratory muscle weakness in children with juvenile chronic arthritis. Eur Respir J 1999; 14: 529-33.
31. HULSKAMP G, LJUNGBERG H, HOO A-F, PILLOW JJ, LUM S, GUSTAFFSON P, STOCKS J: Estimates of plethysmographic FRC exceed those by gas dilution in infants with cystic fibrosis but not in healthy controls. Thorax 2002; 57: III 23.
32. ATHREYA BH, DOUGHTY RA, BOOKSPAN M, SCHUMACHER HR, SEWELL EM, CHATTEN J: Pulmonary manifestations of juvenile rheumatoid arthritis. A report of eight cases and review. Clin Chest Med 1980; 1: 361-74.